Haloperidol decanoate injection technique

Information from the National Library of Medicine Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult) Sexes Eligible for Study:   All Accepts Healthy Volunteers:   No Criteria Inclusion Criteria:

An encephalopathic syndrome (characterized by weakness, lethargy , fever, tremulousness and confusion, extrapyramidal symptoms, leukocytosis , elevated serum enzymes, BUN , and fasting blood sugar) followed by irreversible brain damage has occurred in a few patients treated with lithium plus HALDOL. A causal relationship between these events and the concomitant administration of lithium and HALDOL has not been established; however, patients receiving such combined therapy should be monitored closely for early evidence of neurological toxicity and treatment discontinued promptly if such signs appear.

Haloperidol decanoate injection technique

haloperidol decanoate injection technique

Media:

haloperidol decanoate injection techniquehaloperidol decanoate injection techniquehaloperidol decanoate injection techniquehaloperidol decanoate injection techniquehaloperidol decanoate injection technique

http://buy-steroids.org